Corporate Information | Press & Media | For Investors

[Press Release] Ochsner Lafayette Healthcare Innovation Fund Invests in ThinkGenetic Vision for Genetic Disease Identification in Local Patients

by

ThinkGenetic, Inc. announces the official acceptance of a $500,000 investment from the Ochsner Lafayette General Healthcare Innovation Fund.

Together let’s systematically accelerate detecting at-risk  individuals.

Request a Demo

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.